
The Paradigm Shift in Diagnostics to Support Earlier Diagnosis of Sepsis and Antibiotic Stewardship in the Emergency Department (CE Session)
Includes a Live Web Event on 09/25/2025 at 9:10 AM (PDT)
Description:
This session is part of Sepsis Alliance Summit 2025.
Sepsis remains a leading cause of morbidity and mortality, with timely diagnosis and appropriate antimicrobial use being critical to improving patient outcomes. This session explores the evolving landscape of sepsis diagnostics, with a focus on emerging tools designed to enhance early detection and guide antibiotic stewardship in the Emergency Department (ED). Participants will gain insight into current diagnostic practices, examine gaps that persist in the timely recognition and treatment of suspected sepsis, and learn about innovative technologies poised to transform clinical workflows. The session will also address the practical challenges of implementing new diagnostic solutions, including barriers to adoption and opportunities for integration into ED protocols. Attendees will leave equipped with actionable knowledge to support better clinical decisions and improved patient care in the high-stakes environment of emergency medicine.
Learning Objectives:
At the end of this session, the learner should be able to:
- List current clinical practice and new tools to diagnose sepsis;
- Summarize gaps in diagnosis and antimicrobial stewardship in suspected sepsis;
- Recognize barriers and opportunities for implementation of new diagnostic tests for sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Larissa May, MD, MSPH, MBA
Professor of Emergency Medicine
University of California Davis
Larissa May, MD, MSPH, MBA, is Professor of Emergency Medicine at University of California, Davis Health. Dr. May’s research interests center on the application of rapid diagnostic assays, behavioral economics, and informatics to improve infectious diseases management including sepsis in the emergency department. She is currently a Clinical Partner at the UC Davis Center for Diagnostic Innovation, where she supports clinical development of assays, registrational trials, and post-market implementation studies. She has also served on numerous national and international committees and task forces focused on infectious diseases in acute care. She serves as the co-chair of the American College of Emergency Physicians Technical Expert Panel on sepsis. She is a clinical advisor to the Berkeley SkyDeck and an independent consultant to multiple biotech and life sciences companies in the infectious diseases area.